3-Acetylpyridine → HCID 178523498, Verbindung

HRID 1093746Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1093746
CCN(C(C)C)C(C)C.Cl.[N:11]1[CH:16]=[CH:15][CH:14]=[C:13]([C:17]2[NH:21][N:20]=[C:19]([C:22]([OH:24])=O)[CH:18]=2)[CH:12]=1.C(C1C=NC=CC=1)(=O)C.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.Cl.[NH2:57][CH2:58][C:59]([N:61]1[CH2:66][CH2:65][CH:64]([O:67][C:68]2[CH:73]=[CH:72][CH:71]=[CH:70][C:69]=2[Cl:74])[CH2:63][CH2:62]1)=[O:60]>CN(C=O)C.O>[Cl:74][C:69]1[CH:70]=[CH:71][CH:72]=[CH:73][C:68]=1[O:67][CH:64]1[CH2:63][CH2:62][N:61]([C:59](=[O:60])[CH2:58][NH:57][C:22]([C:19]2[CH:18]=[C:17]([C:13]3[CH:12]=[N:11][CH:16]=[CH:15][CH:14]=3)[NH:21][N:20]=2)=[O:24])[CH2:66][CH2:65]1

Komponenten

9

Versuchsvorschrift

DIPEA (290 mg, 2.26 mmol) to a stirred solution of 5-pyridin-3-yl-1H-pyrazole-3-carboxylic acid hydrochloride (100 mg, 0.44 mmol) (prepared by the method used for the synthesis of Intermediate 29, starting from 3-acetylpyridine) in DMF (2 mL) followed by HOBt (63 mg, 0.46 mmol) and EDCI.HCl (90 mg, 0.46 mmol). After 2 minutes 2-amino-1-[4-(2-chloro-phenoxy)-piperidin-1-yl]-ethanone hydrochloride (150 mg, 0.44 mmol) (prepared according to Step 1 and 5 of the General Scheme) was added to the reaction mixture and stirring was continued at ambient temperature overnight. The reaction mixture was diluted with cold water, extracted with ethyl acetate, dried over sodium sulfate and concentrated under reduced pressure. Purification by recrystallisation from 10% EtOAc in hexane afforded 100 mg (51.5% Yield) of 5-pyridin-3-yl-1H-pyrazole-3-carboxylic acid {2-[4-(2-chloro-phenoxy)-piperidin-1-yl]-2-oxo-ethyl}-amide. LC/MS [M+H]+: 440, 96.47%. 1H NMR (300 MHz, DMSO-d6): δ 13.9 (s, 1H), 9.0 (m, 1H), 8.5 (m, 1H), 8.1 (m, 2H), 7.4 (m, 2H), 7.2 (m, 3H), 6.9 (m, 1H), 4.75 (m, 1H), 4.2 (m, 2H), 3.65 (m, 2H), 3.4 (m, 2H), 1.9 (m, 2H), 1.7 (m, 2H).

Aufarbeitung

  1. additionwas added to the reaction mixture
  2. extractionextracted with ethyl acetate
  3. dry with materialdried over sodium sulfate
  4. concentrationconcentrated under reduced pressure
  5. customPurification
  6. customby recrystallisation from 10% EtOAc in hexane

Quellen und Nachweise

ORD-Eintrag
ord-68971535dfff4c62ac47221c92b71a32
Quelldatensatz
uspto-grants-2012_03
Patentnummer
US08129376B2

Notizen zur Reaktion

Wird geladen…